BioSpace News Archive

Dimerix to Present at the 2nd World Congress for Clinical Trials in Diabetes

The World Congress for Clinical Trials in Diabetes will bring together over 300 representatives from regulatory agencies and the pharmaceutical industry across a range of disciplines including endocrinologists, cardiologists, neurologists and nephrologists.

November 27, 2017
·
2 min read
Drug Development

TG Therapeutics Announces Initiation of National Cancer Institute/SWOG-Sponsored Randomized Phase II Trial in Follicular Lymphoma

TGR-1202 (umbralisib) selected as the PI3K Delta inhibitor to be used in this multiple arm comparison study

November 27, 2017
·
5 min read
Business

Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development

Dr. Weyer most recently served as President and Chief Development Officer of ProSciento,

November 27, 2017
·
5 min read
BASF to Increase Prices for Formic Acid and Propionic Acid in the EMEA Region

Prices for all other concentrations of Formic Acid will be increased accordingly on a pro rata basis.

November 27, 2017
·
1 min read
VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day

This represents the first time the Canadian public will have direct access to their HIV status within 60 seconds in a community pharmacy, since the program was successfully piloted in July 2014.

November 27, 2017
·
5 min read
Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, to Present at CBI’s Biopharma Forum on Cannabis-Based Therapies

Teewinot announced today it will be presenting at CBI’s Biopharma Forum on Cannabis-Based Therapies conference on Thursday, November 30th in Denver, CO.

November 27, 2017
·
2 min read
Business

Microbix Confirms Ramp-up of Production Bioreactor Capacity Increasing by 500%

Microbix’s revenues are mainly from sales of its antigens as critical components for makers of tests that diagnose infectious diseases.

November 27, 2017
·
4 min read
JPMorgan Chase & Co Notifies 3.12% Shareholding in TiGenix

TiGenix publishes today a transparency notification pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated market and including various provisions.

November 27, 2017
·
2 min read
Medical Artificial Intelligence Company Quantib Receives Capital Injection of EUR 4.5 Million

The presentation of Prof. Hartmut Ehrlich, M.D., CEO of ABIVAX is scheduled for Tuesday, November 28th, 11:30am CET in Room Oslo.

November 27, 2017
·
2 min read
BioMidwest

Aratana Announces Proposed Public Offering

Aratana Therapeutics today announced that it is commencing an underwritten registered public offering of $35,000,000 of shares of its common stock.

November 27, 2017
·
1 min read